美国FDA生物制品紫皮书数据库（U.S. FDA Purple Book: Database of Licensed Biological Products）- 药物在线

商品名	申请号	产品号	BLA类型	非专利名称	剂型	给药途径	规格/剂量	产品形式	批准日期	申请人	市场状态	许可证状态	参考产品非专利名称	参考产品专利名称
Datroway	761394	001	351(a)	datopotamab deruxtecan-dlnk	Injection	Intravenous	100MG	Single-Dose Vial	2025/01/17	Daiichi Sankyo, Inc	Rx	Licensed
Omvoh	761279	003	351(a)	mirikizumab-mrkz	Injection	Subcutaneous	100MG/ML	Autoinjector	2025/01/15	Eli Lilly and Company	Rx	Licensed
Omvoh	761279	004	351(a)	mirikizumab-mrkz	Injection	Subcutaneous	200MG/2ML (100MG/ML)	Autoinjector	2025/01/15	Eli Lilly and Company	Rx	Licensed
Omvoh	761279	005	351(a)	mirikizumab-mrkz	Injection	Subcutaneous	200MG/2ML (100MG/ML)	Pre-Filled Syringe	2025/01/15	Eli Lilly and Company	Rx	Licensed
Opdivo Qvantig	761381	001	351(a)	nivolumab and hyaluronidase-nvhy	Injection	Subcutaneous	600MG/5ML;10,000 UNITS/5ML (120MG/2,000UNITS/ML)	Single-Dose Vial	2024/12/27	Bristol-Myers Squibb Company	Rx	Licensed
Wezlana	761285	004	351(k) Biosimilar	ustekinumab-auub	Injection	Subcutaneous	45MG/0.5ML	Autoinjector	2024/12/26	Amgen Inc.	Rx	Licensed	ustekinumab	Stelara
Wezlana	761285	005	351(k) Biosimilar	ustekinumab-auub	Injection	Subcutaneous	90MG/ML	Autoinjector	2024/12/26	Amgen Inc.	Rx	Licensed	ustekinumab	Stelara
Pyzchiva	761373	003	351(k) Biosimilar	ustekinumab-ttwe	Injection	Subcutaneous	45MG/0.5ML	Single-Dose Vial	2024/12/20	Samsung Bioepis Co., Ltd.	Rx	Licensed	ustekinumab	Stelara
Alhemo	761315	001	351(a)	concizumab-mtci	Injection	Subcutaneous	60MG/1.5ML (40MG/ML)	Autoinjector	2024/12/20	Novo Nordisk Inc.	Rx	Licensed
Alhemo	761315	002	351(a)	concizumab-mtci	Injection	Subcutaneous	150MG/1.5ML (100MG/ML)	Autoinjector	2024/12/20	Novo Nordisk Inc.	Rx	Licensed
Alhemo	761315	003	351(a)	concizumab-mtci	Injection	Subcutaneous	300MG/3ML (100MG/ML)	Autoinjector	2024/12/20	Novo Nordisk Inc.	Rx	Licensed
symvess	125812	001	351(a)	acellular tissue engineered vessel-tyod	Implant	Implantation	6 MM INTERNAL DIAMETER,~42 CM LENGTH	Tray & Lid	2024/12/19	Humacyte Global Inc.	Rx	Licensed
ryoncil	125706	001	351(a)	remestemcel-L-rknd	Suspension	Intravenous	6.68X10^CELL/ML	Single-Dose Vial	2024/12/18	Mesoblast, Inc.	Rx	Licensed
Steqeyma	761338	001	351(k) Biosimilar	ustekinumab-stba	Injection	Subcutaneous	45MG/0.5ML	Pre-Filled Syringe	2024/12/17	CELLTRION, Inc.	Rx	Licensed	ustekinumab	Stelara
Steqeyma	761338	002	351(k) Biosimilar	ustekinumab-stba	Injection	Subcutaneous	90MG/ML	Pre-Filled Syringe	2024/12/17	CELLTRION, Inc.	Rx	Licensed	ustekinumab	Stelara
Steqeyma	761338	003	351(k) Biosimilar	ustekinumab-stba	Injection	Intravenous	130MG/26ML (5MG/ML)	Single-Dose Vial	2024/12/17	CELLTRION, Inc.	Rx	Licensed	ustekinumab	Stelara
Unloxcyt	761297	001	351(a)	cosibelimab-ipdl	Injection	Intravenous	300MG/5ML (60MG/ML)	Single-Dose Vial	2024/12/13	Checkpoint Therapeutics, Inc.	Rx	Licensed
Bizengri	761352	001	351(a)	zenocutuzumab-zbco	Injection	Intravenous	375MG/18.75ML (20MG/ML)	Single-Dose Vial	2024/12/04	Merus NV	Rx	Licensed
Yesintek	761406	001	351(k) Biosimilar	ustekinumab-kfce	Injection	Subcutaneous	45MG/0.5ML	Single-Dose Vial	2024/11/29	Biocon Biologics Inc.	Rx	Licensed	ustekinumab	Stelara
Yesintek	761406	002	351(k) Biosimilar	ustekinumab-kfce	Injection	Subcutaneous	45MG/0.5ML	Pre-Filled Syringe	2024/11/29	Biocon Biologics Inc.	Rx	Licensed	ustekinumab	Stelara

药品商品名或专利药名Proprietary (Brand) Name
药品通用名或非专利名称Nonproprietary (Proper) Name
药品申请号BLA Number
产品号Product Number
剂型Dosage Form
给药途径Route of Administration
产品形式Product Presentation
药品规格或剂量Strength
药品注册申请人Applicant
参考产品非专利名称Reference Product Proper Name
参考产品专利名称Reference Product Proprietary Name
BLA类型BLA Type
药品的市场状态Marketing Status
许可证号License Number
许可证状态Licensure
产品批准日期Approval Date	-